TTOO
T2 Biosystems, Inc.
Price Chart
Latest Quote
$0.00
-0.00 (-80.00%)
Current Price
| Previous Close | $0.00 |
| Open | $0.01 |
| Day High | $0.01 |
| Day Low | $0.01 |
| Volume | 35 |
Stock Information
| Shares Outstanding | 28.05M |
| Total Debt | $18.94M |
| Cash Equivalents | $2.08M |
| Revenue | $7.68M |
| Net Income | $-42.95M |
| Sector | Healthcare |
| Industry | Diagnostics & Research |
| Market Cap | $11K |
| EPS (TTM) | $-0.03 |
| Exchange | PNK |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $16.87M |
| Sales | $7.68M |
| Income | $-42.95M |
| Book/sh | $-0.62 |
| Cash/sh | $0.07 |
| Employees | 113 |
Financial Ratios
| Quick Ratio | 0.17 |
| Current Ratio | 0.40 |
Returns & Margins
| ROA | -84.85% |
| Gross Margin | -247.83% |
| Operating Margin | -511.89% |
Ownership
| Insider Ownership | 5.38% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| Forward P/E | -0.00 |
| P/S | 0.00 |
| P/B | -0.00 |
Analyst Data
| Recommendation | none |
Technical Indicators
| SMA20 | $0.00 |
| SMA50 | $0.00 |
| SMA200 | $0.01 |
| RSI | 47.62 |
| ATR | 0.0009 |
| Shares Float | 11.90M |
| Short Float | 4.87% |
| Short Ratio | 0.71 |
| Volatility | 7.87 |
| Rel Volume | 1.23 |
Performance History
| Week | +0.00% |
| Month | -42.86% |
| Quarter | -86.67% |
| 6 Months | -96.36% |
| YTD | -92.00% |
| Year | -99.75% |
| 3 Years | -100.00% |
| 5 Years | -100.00% |
| 10 Years | -100.00% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-04 | $0.00 | 5,233 |
| 2026-06-03 | $0.00 | 0 |
| 2026-06-02 | $0.00 | 2,424 |
| 2026-06-01 | $0.00 | 760 |
| 2026-05-29 | $0.00 | 1,029 |
| 2026-05-28 | $0.00 | 26,043 |
| 2026-05-27 | $0.00 | 283 |
| 2026-05-26 | $0.00 | 9,819 |
| 2026-05-22 | $0.00 | 26,082 |
| 2026-05-21 | $0.00 | 348 |
| 2026-05-20 | $0.00 | 0 |
| 2026-05-19 | $0.00 | 0 |
| 2026-05-18 | $0.00 | 666 |
| 2026-05-15 | $0.00 | 6,762 |
| 2026-05-14 | $0.00 | 329 |
| 2026-05-13 | $0.00 | 0 |
| 2026-05-12 | $0.00 | 357 |
| 2026-05-11 | $0.00 | 4,200 |
| 2026-05-08 | $0.00 | 263 |
| 2026-05-07 | $0.00 | 232 |
| 2026-05-06 | $0.00 | 0 |
| 2026-05-05 | $0.00 | 6,691 |
About T2 Biosystems, Inc.
T2 Biosystems, Inc. engages in the development and commercialization of medical diagnostic products for critical unmet needs in the healthcare. Its products include T2Dx instrument, T2Candida panel, and T2Bacteria panel. The company was incorporated in 2006 and is based in Lexington, Massachusetts.
đ° Latest News
No news articles available at the moment. Check back later for updates on TTOO.
Period:
Loading...
Income Statement (Annual)
| Metric | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|
| Revenue | |||
| Reconciled Cost Of Revenue | $15,363,000 | $21,010,000 | $20,703,000 |
| Cost Of Revenue | $15,363,000 | $21,010,000 | $20,703,000 |
| Total Revenue | $7,193,000 | $22,305,000 | $28,058,000 |
| Operating Revenue | $7,193,000 | $22,305,000 | $28,058,000 |
| Expenses | |||
| Interest Expense | $5,343,000 | $6,084,000 | $7,596,000 |
| Total Expenses | $54,346,000 | $77,350,000 | $71,031,000 |
| Other Income Expense | $2,419,000 | $-874,000 | $1,216,000 |
| Other Non Operating Income Expenses | $-495,000 | $39,000 | $206,000 |
| Net Non Operating Interest Income Expense | $-5,343,000 | $-6,084,000 | $-7,484,000 |
| Interest Expense Non Operating | $5,343,000 | $6,084,000 | $7,596,000 |
| Operating Expense | $38,983,000 | $56,340,000 | $50,328,000 |
| Income & Earnings | |||
| Net Income From Continuing Operation Net Minority Interest | $-50,077,000 | $-62,003,000 | $-49,241,000 |
| Net Interest Income | $-5,343,000 | $-6,084,000 | $-7,484,000 |
| Normalized Income | $-52,991,000 | $-61,090,000 | $-50,251,000 |
| Net Income From Continuing And Discontinued Operation | $-50,077,000 | $-62,003,000 | $-49,241,000 |
| Total Operating Income As Reported | $-49,664,000 | $-55,196,000 | $-42,973,000 |
| Net Income Common Stockholders | $-50,077,000 | $-62,333,000 | $-49,241,000 |
| Net Income | $-50,077,000 | $-62,003,000 | $-49,241,000 |
| Net Income Including Noncontrolling Interests | $-50,077,000 | $-62,003,000 | $-49,241,000 |
| Net Income Continuous Operations | $-50,077,000 | $-62,003,000 | $-49,241,000 |
| Pretax Income | $-50,077,000 | $-62,003,000 | $-49,241,000 |
| Special Income Charges | $-2,511,000 | $-151,000 | - |
| Operating Income | $-47,153,000 | $-55,045,000 | $-42,973,000 |
| Gross Profit | $-8,170,000 | $1,295,000 | $7,355,000 |
| Interest Income | - | $8,000 | $112,000 |
| Interest Income Non Operating | - | $8,000 | $112,000 |
| Per Share | |||
| Diluted EPS | $-19.19 | $-1228.00 | $-31.00 |
| Basic EPS | $-19.19 | $-1228.00 | $-31.00 |
| Other | |||
| Tax Effect Of Unusual Items | $0 | $0 | $0 |
| Tax Rate For Calcs | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $-46,789,000 | $-53,959,000 | $-40,117,000 |
| Total Unusual Items | $2,914,000 | $-913,000 | $1,010,000 |
| Total Unusual Items Excluding Goodwill | $2,914,000 | $-913,000 | $1,010,000 |
| Reconciled Depreciation | $859,000 | $1,047,000 | $2,538,000 |
| EBITDA (Bullshit earnings) | $-43,875,000 | $-54,872,000 | $-39,107,000 |
| EBIT | $-44,734,000 | $-55,919,000 | $-41,645,000 |
| Diluted Average Shares | $2,609,984 | $51,003 | $1,588,614 |
| Basic Average Shares | $2,609,984 | $51,003 | $1,588,614 |
| Diluted NI Availto Com Stockholders | $-50,077,000 | $-62,333,000 | $-49,241,000 |
| Impairment Of Capital Assets | $2,511,000 | $151,000 | - |
| Gain On Sale Of Security | $5,425,000 | $-762,000 | $1,010,000 |
| Research And Development | $14,153,000 | $25,715,000 | $21,801,000 |
| Selling General And Administration | $24,830,000 | $30,625,000 | $28,527,000 |
| Preferred Stock Dividends | - | $330,000 | - |
Fetched: 2026-02-02
Balance Sheet (Annual)
| Metric | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|
| Assets | |||
| Net Tangible Assets | $-28,036,000 | $-39,655,000 | $-12,903,000 |
| Total Assets | $34,797,000 | $34,327,000 | $60,539,000 |
| Total Non Current Assets | $9,608,000 | $14,968,000 | $16,145,000 |
| Other Non Current Assets | $555,000 | $1,694,000 | $1,704,000 |
| Current Assets | $25,189,000 | $19,359,000 | $44,394,000 |
| Other Current Assets | $3,261,000 | $2,582,000 | $3,110,000 |
| Inventory | $4,819,000 | $4,285,000 | $3,909,000 |
| Receivables | $1,420,000 | $2,163,000 | $5,134,000 |
| Accounts Receivable | $1,420,000 | $2,163,000 | $5,134,000 |
| Allowance For Doubtful Accounts Receivable | $-100,000 | $-100,000 | - |
| Gross Accounts Receivable | $1,520,000 | $2,263,000 | $5,134,000 |
| Cash Cash Equivalents And Short Term Investments | $15,689,000 | $10,329,000 | $32,241,000 |
| Cash And Cash Equivalents | $15,689,000 | $10,329,000 | $22,245,000 |
| Investmentin Financial Assets | - | - | $0 |
| Prepaid Assets | - | - | $3,110,000 |
| Debt | |||
| Net Debt | $25,595,000 | $39,322,000 | $25,545,000 |
| Total Debt | $49,498,000 | $59,217,000 | $58,323,000 |
| Long Term Debt And Capital Lease Obligation | $6,598,000 | $57,865,000 | $57,149,000 |
| Current Debt And Capital Lease Obligation | $42,900,000 | $1,352,000 | $1,174,000 |
| Current Debt | $41,284,000 | - | - |
| Other Current Borrowings | $41,284,000 | - | - |
| Long Term Debt | - | $49,651,000 | $47,790,000 |
| Liabilities | |||
| Total Liabilities Net Minority Interest | $62,833,000 | $73,982,000 | $73,442,000 |
| Total Non Current Liabilities Net Minority Interest | $6,681,000 | $63,854,000 | $61,754,000 |
| Derivative Product Liabilities | $0 | $1,088,000 | $0 |
| Non Current Deferred Liabilities | $83,000 | $52,000 | $28,000 |
| Current Liabilities | $56,152,000 | $10,128,000 | $11,688,000 |
| Other Current Liabilities | $1,789,000 | $39,000 | - |
| Current Deferred Liabilities | $224,000 | $172,000 | $518,000 |
| Payables And Accrued Expenses | $11,239,000 | $8,565,000 | $9,996,000 |
| Interest Payable | $839,000 | $1,009,000 | $974,000 |
| Payables | $1,527,000 | $1,296,000 | $2,832,000 |
| Accounts Payable | $1,527,000 | $1,296,000 | $2,832,000 |
| Other Non Current Liabilities | - | $4,849,000 | $4,577,000 |
| Equity | |||
| Common Stock Equity | $-28,036,000 | $-39,655,000 | $-12,903,000 |
| Total Equity Gross Minority Interest | $-28,036,000 | $-39,655,000 | $-12,903,000 |
| Stockholders Equity | $-28,036,000 | $-39,655,000 | $-12,903,000 |
| Retained Earnings | $-584,296,000 | $-534,219,000 | $-472,216,000 |
| Gains Losses Not Affecting Retained Earnings | - | $0 | $-4,000 |
| Other | |||
| Ordinary Shares Number | $4,058,381 | $77,165 | $1,664,008 |
| Share Issued | $4,058,381 | $77,165 | $1,664,008 |
| Tangible Book Value | $-28,036,000 | $-39,655,000 | $-12,903,000 |
| Invested Capital | $13,248,000 | $9,996,000 | $34,887,000 |
| Working Capital | $-30,963,000 | $9,231,000 | $32,706,000 |
| Capital Lease Obligations | $8,214,000 | $9,566,000 | $10,533,000 |
| Total Capitalization | $-28,036,000 | $9,996,000 | $34,887,000 |
| Additional Paid In Capital | $556,256,000 | $494,564,000 | $459,314,000 |
| Capital Stock | $4,000 | $0 | $3,000 |
| Common Stock | $4,000 | $0 | $3,000 |
| Preferred Stock | $0 | $0 | $0 |
| Non Current Accrued Expenses | $0 | $4,849,000 | - |
| Non Current Deferred Revenue | $83,000 | $52,000 | $28,000 |
| Long Term Capital Lease Obligation | $6,598,000 | $8,214,000 | $9,359,000 |
| Current Deferred Revenue | $224,000 | $172,000 | $518,000 |
| Current Capital Lease Obligation | $1,616,000 | $1,352,000 | $1,174,000 |
| Current Accrued Expenses | $9,712,000 | $7,269,000 | $7,164,000 |
| Net PPE | $9,053,000 | $13,274,000 | $14,441,000 |
| Accumulated Depreciation | $-14,851,000 | $-14,257,000 | $-14,977,000 |
| Gross PPE | $23,904,000 | $27,531,000 | $29,418,000 |
| Leases | $3,608,000 | $3,784,000 | $3,768,000 |
| Construction In Progress | $23,000 | $685,000 | $512,000 |
| Other Properties | $18,587,000 | $21,325,000 | $23,409,000 |
| Machinery Furniture Equipment | $1,686,000 | $1,737,000 | $1,729,000 |
| Properties | $0 | $0 | $0 |
| Finished Goods | $1,497,000 | $1,105,000 | $1,365,000 |
| Work In Process | $1,441,000 | $1,176,000 | $953,000 |
| Raw Materials | $1,881,000 | $2,004,000 | $1,591,000 |
| Other Short Term Investments | - | $0 | $9,996,000 |
| Investments And Advances | - | - | $0 |
Fetched: 2026-02-02
Cash Flow Statement (Annual)
| Metric | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|
| Free Cash Flow | |||
| Free Cash Flow | $-48,328,000 | $-50,968,000 | $-39,334,000 |
| Operating Activities | |||
| Operating Cash Flow | $-48,136,000 | $-50,629,000 | $-38,874,000 |
| Cash Flow From Continuing Operating Activities | $-48,136,000 | $-50,629,000 | $-38,874,000 |
| Operating Gains Losses | $-5,422,000 | $829,000 | $-1,024,000 |
| Investing Activities | |||
| Capital Expenditure | $-192,000 | $-339,000 | $-460,000 |
| Investing Cash Flow | $-192,000 | $9,659,000 | $24,791,000 |
| Cash Flow From Continuing Investing Activities | $-192,000 | $9,659,000 | $24,791,000 |
| Financing Activities | |||
| Repurchase Of Capital Stock | $0 | $-330,000 | $0 |
| Issuance Of Capital Stock | $52,731,000 | $29,462,000 | $19,968,000 |
| Financing Cash Flow | $52,688,000 | $29,054,000 | $20,535,000 |
| Cash Flow From Continuing Financing Activities | $52,688,000 | $29,054,000 | $20,535,000 |
| Net Other Financing Charges | $-62,000 | $-243,000 | - |
| Net Preferred Stock Issuance | $0 | $-30,000 | $0 |
| Preferred Stock Issuance | $0 | $300,000 | $0 |
| Net Common Stock Issuance | $52,731,000 | $29,162,000 | $19,968,000 |
| Common Stock Issuance | $52,731,000 | $29,162,000 | $19,968,000 |
| Other | |||
| Interest Paid Supplemental Data | $3,860,000 | $3,917,000 | $3,814,000 |
| End Cash Position | $16,240,000 | $11,880,000 | $23,796,000 |
| Beginning Cash Position | $11,880,000 | $23,796,000 | $17,344,000 |
| Changes In Cash | $4,360,000 | $-11,916,000 | $6,452,000 |
| Proceeds From Stock Option Exercised | $19,000 | $165,000 | $567,000 |
| Preferred Stock Payments | $0 | $-330,000 | $0 |
| Net Investment Purchase And Sale | $0 | $9,998,000 | $25,251,000 |
| Sale Of Investment | $0 | $9,998,000 | $25,251,000 |
| Net PPE Purchase And Sale | $-192,000 | $-339,000 | $-460,000 |
| Purchase Of PPE | $-192,000 | $-339,000 | $-460,000 |
| Change In Working Capital | $-4,042,000 | $-503,000 | $-2,171,000 |
| Change In Other Working Capital | $83,000 | $-322,000 | $-108,000 |
| Change In Other Current Liabilities | $-1,352,000 | $-1,369,000 | $-1,151,000 |
| Change In Payables And Accrued Expense | $-2,222,000 | $-1,305,000 | $1,530,000 |
| Change In Accrued Expense | $-2,453,000 | $261,000 | $769,000 |
| Change In Payable | $231,000 | $-1,566,000 | $761,000 |
| Change In Account Payable | $231,000 | $-1,566,000 | $761,000 |
| Change In Prepaid Assets | $-550,000 | $471,000 | $-467,000 |
| Change In Inventory | $-744,000 | $-949,000 | $-1,940,000 |
| Change In Receivables | $743,000 | $2,971,000 | $-35,000 |
| Changes In Account Receivables | $743,000 | $2,971,000 | $-35,000 |
| Other Non Cash Items | $3,684,000 | $3,357,000 | $3,934,000 |
| Stock Based Compensation | $4,351,000 | $6,493,000 | $7,090,000 |
| Asset Impairment Charge | $2,511,000 | $151,000 | $0 |
| Depreciation Amortization Depletion | $859,000 | $1,047,000 | $2,538,000 |
| Depreciation And Amortization | $859,000 | $1,047,000 | $2,538,000 |
| Gain Loss On Investment Securities | $-5,425,000 | $829,000 | $-1,024,000 |
| Gain Loss On Sale Of PPE | $3,000 | $0 | $0 |
| Net Income From Continuing Operations | $-50,077,000 | $-62,003,000 | $-49,241,000 |
| Depreciation | - | $2,271,000 | $2,538,000 |
| Purchase Of Investment | - | - | $0 |
| Sale Of PPE | - | - | $0 |
Fetched: 2026-02-02